Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
Visual field impairment captures disease burden in multiple sclerosis.
Multiple sclerosis: autoimmunity and viruses.
Test-retest reliability of four sensory measures in people with multiple sclerosis.
Epigenetic Drugs for Multiple Sclerosis.
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
How do carers of people with multiple sclerosis engage with websites containing the personal experiences of other carers and patients?
Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
MRI to Discriminate Pediatric MS from ADEM.
Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
Allopregnanolone: State of the art.
Diffusion MRI abnormalities detection with orientation distribution functions: A multiple sclerosis longitudinal study.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
A tissue-relaxation-dependent neighboring method for robust mapping of the myelin water fraction.

Pages